149 related articles for article (PubMed ID: 29928421)
1. The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells.
Li H; Fan Y; Yang F; Zhao L; Cao B
Oncol Lett; 2018 Jul; 16(1):353-361. PubMed ID: 29928421
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicine
Wu J; Wang J; Su Q; Ding W; Li T; Yu J; Cao B
Onco Targets Ther; 2018; 11():2685-2698. PubMed ID: 29785118
[TBL] [Abstract][Full Text] [Related]
3. Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.
Zhen H; Li G; Zhao P; Zhang Y; Wang J; Yu J; Cao B
Onco Targets Ther; 2020; 13():12325-12339. PubMed ID: 33293826
[TBL] [Abstract][Full Text] [Related]
4. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
5. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
[TBL] [Abstract][Full Text] [Related]
6. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
7. Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma.
Yu X; Fan H; Jiang X; Zheng W; Yang Y; Jin M; Ma X; Jiang W
Oncol Lett; 2020 Oct; 20(4):52. PubMed ID: 32788939
[TBL] [Abstract][Full Text] [Related]
8. Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway.
Wu J; Yu J; Wang J; Zhang C; Shang K; Yao X; Cao B
Biomed Pharmacother; 2018 Apr; 100():176-183. PubMed ID: 29428665
[TBL] [Abstract][Full Text] [Related]
9. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
10. Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy.
Ma Y; Yu J; Li Q; Su Q; Cao B
Biosci Biotechnol Biochem; 2020 Apr; 84(4):743-756. PubMed ID: 31889475
[TBL] [Abstract][Full Text] [Related]
11. Apatinib regulates the growth of gastric cancer cells by modulating apoptosis and autophagy.
Liu X; Zheng Q; Yu Q; Hu Y; Cheng Y; Shao Z; Chen L; Ding W; Gao D
Naunyn Schmiedebergs Arch Pharmacol; 2021 May; 394(5):1009-1018. PubMed ID: 33205247
[TBL] [Abstract][Full Text] [Related]
12. Apatinib promotes apoptosis of the SMMC-7721 hepatocellular carcinoma cell line via the PI3K/Akt pathway.
Zhang H; Cao Y; Chen Y; Li G; Yu H
Oncol Lett; 2018 Apr; 15(4):5739-5743. PubMed ID: 29552208
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of apatinib on HCT-116 cells and its mechanism].
Yin L; Wang J; Huang FC; Zhang YF; Xu N; Wen ZQ; Li WL; Dong J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):367-372. PubMed ID: 28377354
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo apatinib inhibits vasculogenic mimicry in melanoma MUM-2B cells.
Liu ZJ; Zhou YJ; Ding RL; Xie F; Fu SZ; Wu JB; Yang LL; Wen QL
PLoS One; 2018; 13(7):e0200845. PubMed ID: 30052652
[TBL] [Abstract][Full Text] [Related]
15. Tripterine inhibits proliferation, migration and invasion of breast cancer MDA-MB-231 cells by up-regulating microRNA-15a.
Zuo A; Zhao P; Zheng Y; Hua H; Wang X
Biol Chem; 2019 Jul; 400(8):1069-1078. PubMed ID: 30913029
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of apatinib on HL-60 cell proliferation and its mechanism].
Liang S; Tong XZ; Fu LW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):871-4. PubMed ID: 21602146
[TBL] [Abstract][Full Text] [Related]
17. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.
Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778
[TBL] [Abstract][Full Text] [Related]
18. Apatinib inhibits gastric carcinoma development by regulating the expression levels of IL-17 via the Bax/Bcl-2 signaling pathway.
Wang T; Zhang J; Cui L
Exp Ther Med; 2021 Jun; 21(6):654. PubMed ID: 33968184
[TBL] [Abstract][Full Text] [Related]
19. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
[TBL] [Abstract][Full Text] [Related]
20. Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells.
Li Y; He F; Zhang Y; Pan Z
Dis Markers; 2022; 2022():3833489. PubMed ID: 35069931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
